HOMEBASE
Portland, Oregon
Operating at the intersection of biotechnology and capital markets, Kate speaks both science and strategy. She helps clients translate complex innovation into compelling market value, navigate pivotal milestones, and build enduring credibility with stakeholders.
Career and education
- 20+ years of biotech investor relations and corporate communications leadership in public and private companies
- Experience with IPO execution, high-profile data disclosures, and strategic rebranding campaigns
- Former sell-side equity analyst covering small- and mid-cap biotech companies
- Ph.D. in Pharmacology and Cancer Biology, Duke University; B.A. in Biology, Swarthmore College
Standout skills
Deep scientific fluency, impactful investor-focused communications, strategic narrative development
Beyond the office
Weekend hiker, enthusiastic traveler (and chief family trip planner), amateur potter
Unscripted accomplishments
I’ve nailed a combat hand roll paddling the Lower Gauley (whitewater kayaking, iykyk), and I spent a season as a commercial salmon fisher in Alaska